Understanding dermatan sulfate-heparin cofactor II interaction through virtual library screening

ACS Medicinal Chemistry Letters

Volumn 1, Issue 6, 2010, Pages 281-285

  Raghuraman, Arjun ^a   Mosier, Philip D ^a   Desai, Umesh R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Computational biology; dermatansulfate; glycosaminoglycans; heparin cofactor II; serpins; structure activity relationships

Indexed keywords

DERMATAN SULFATE; HEPARIN COFACTOR II; THROMBIN;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; GENETIC ALGORITHM; MUTAGENESIS; PRIORITY JOURNAL;

EID: 77956521262     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml100048y     Document Type: Article

References (33)

1. Capila, I.; Linhardt, R. J. Heparin-Protein Interactions Angew. Chem., Int. Ed. Engl. 2002, 41, 391-412
2. Desai, U. R. New Antithrombin-Based Anticoagulants Med. Res. Rev. 2004, 24, 151-181
3. Gandhi, N. S.; Mancera, R. L. The Structure of Glycosaminoglycans and Their Interactions with Proteins Chem. Biol. Drug Des. 2008, 72, 455-482
4. Mitra, A. K.; Arnott, S.; Atkins, E. D. T.; Isaac, D. H. Dermatan Sulfate: Molecular Conformations and Interactions in the Condensed State J. Mol. Biol. 1983, 169, 873-901
5. Ragazzi, M.; Ferro, D. R.; Provasoli, A. A. Force-Field Study of the Conformational Characteristics of the Iduronate Ring J. Comput. Chem. 1986, 7, 105-112
6. Venkataraman, G.; Sasisekharan, V.; Cooney, C. L.; Langer, R.; Sasisekharan, R. A. Stereochemical Approach to Pyranose Ring Flexibility: Its Implications for the Conformation of Dermatan Sulfate Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 6171-6175
7. Grootenhuis, P. D. J.; van Boeckel, C. A. A. Constructing a Molecular Model of the Interaction Between Antithrombin III and a Potent Heparin Analog J. Am. Chem. Soc. 1991, 113, 2743-2747
8. Bitomsky, W.; Wade, R. C. Docking of Glycosaminoglycans to Heparin-Binding Proteins: Validation for aFGF, bFGF, and Antithrombin and Application to IL-8 J. Am. Chem. Soc. 1999, 121, 3004-3013
9. Raghuraman, A.; Mosier, P. D.; Desai, U. R. Finding Needle in a Haystack. Development of a Combinatorial Virtual Screening Approach for Identifying High Specificity Heparin/Heparan Sulfate Sequence(s) J. Med. Chem. 2006, 49, 3553-3562
10. Weitz, J. I.; Hudoba, M.; Massel, D.; Maraganore, J.; Hirsh, J. Clot-Bound Thrombin is Protected from Inhibition by Heparin-Antithrombin III but is Susceptible to Inactivation by Antithrombin III-Independent Inhibitors J. Clin. Invest. 1990, 86, 385-391
11. He, L.; Vicente, C. P.; Westrick, R. J.; Eitzman, D. T.; Tollefsen, D. M. Heparin Cofactor II Inhibits Arterial Thrombosis after Endothelial Injury J. Clin. Invest. 2002, 109, 213-219
12. Aihara, K.-I.; Azuma, H.; Takamori, N.; Kanagawa, Y.; Akaike, M.; Fujimura, M.; Yoshida, T.; Hashizume, S.; Kato, M.; Yamaguchi, H.; Kato, S.; Ikeda, Y.; Arase, T.; Kondo, A.; Matsumoto, T. Heparin Cofactor II is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals Circulation 2004, 109, 2761-2765
13. Vicente, C. P.; He, L.; Pavão, M. S. G.; Tollefsen, D. M. Antithrombotic Activity of Dermatan Sulfate in Heparin Cofactor II-Deficient Mice Blood 2004, 104, 3965-3970
14. Tollefsen, D. M. Heparin Cofactor II Adv. Exp. Med. Biol. 1997, 425, 35-44
15. Tollefsen, D. M. Heparin Cofactor II Deficiency Arch. Pathol. Lab. Med. 2002, 126, 1394-1400
16. Takamori, N.; Azuma, H.; Kato, M.; Hashizume, S.; Aihara, K.-I; Akaike, M.; Tamura, K.; Matsumoto, T. High Plasma Heparin Cofactor II Activity is Associated with Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention Circulation 2004, 109, 481-486
17. Bendayan, P.; Boccalon, H.; Dupouy, D.; Boneu, B. Dermatan Sulfate is a More Potent Inhibitor of Clot-Bound Thrombin than Unfractionated and Low Molecular Weight Heparins Thromb. Haemostasis 1994, 71, 576-580
18. Maimone, M. M.; Tollefsen, D. M. Structure of a Dermatan Sulfate Hexasaccharide that Binds to Heparin Cofactor II with High Affinity J. Biol. Chem. 1990, 265, 18263-18271
19. Pavão, M. S.; Mourão, P. A.; Mulloy, B.; Tollefsen, D. M. A Unique Dermatan Sulfate-like Glycosaminoglycan from Ascidian. Its Structure and the Effect of its Unusual Sulfation Pattern on Anticoagulant Activity J. Biol. Chem. 1995, 270, 31027-31036
20. Maimone, M. M.; Tollefsen, D. M. Activation of Heparin Cofactor II by Heparin Oligosaccharides Biochem. Biophys. Res. Commun. 1988, 152, 1056-1061
21. Blinder, M. A.; Tollefsen, D. M. Site-Directed Mutagenesis of Arginine 103 and Lysine 185 in the Proposed Glycosaminoglycan-Binding Site of Heparin Cofactor II J. Biol. Chem. 1990, 265, 286-291
22. Whinna, H. C.; Blinder, M. A.; Szewczyk, M.; Tollefsen, D. M.; Church, F. C. Role of Lysine 173 in Heparin Binding to Heparin Cofactor II J. Biol. Chem. 1991, 266, 8129-8135
23. Baglin, T. P.; Carrell, R. W.; Church, F. C.; Esmon, C. T.; Huntington, J. A. Crystal Structures of Native and Thrombin-Complexed Heparin Cofactor II Reveal a Multistep Allosteric Mechanism Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11079-11084
24. Jin, L.; Abrahams, J. P.; Skinner, R.; Petitou, M.; Pike, R. N.; Carrell, R. W. The Anticoagulant Activation of Antithrombin by Heparin Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14683-14688
25. Li, W.; Johnson, D. J. D.; Esmon, C. T.; Huntington, J. A. Structure of the Antithrombin-Thrombin-Heparin Ternary Complex Reveals the Antithrombotic Mechanism of Heparin Nat. Struct. Mol. Biol. 2004, 11, 857-862
26. Oslo. Mutation of Arg-189 to His Decreases the Affinity for Dermatan Sulfate J. Biol. Chem. 1989, 264, 5128-5133
27. Liaw, P. C. Y.; Austin, R. C.; Fredenburgh, J. C.; Stafford, A. R.; Weitz, J. I. Comparison of Heparin-and Dermatan Sulfate-Mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II J. Biol. Chem. 1999, 274, 27597-27604
28. He, L.; Giri, T. K.; Vicente, C. P.; Tollefsen, D. M. Vascular Dermatan Sulfate Regulates the Antithrombotic Activity of Heparin Cofactor II Blood 2008, 111, 4118-4125
29. Hayakawa, Y.; Hirashima, Y.; Kurimoto, M.; Hayashi, N.; Hamada, H.; Kuwayama, N.; Endo, S. Contribution of Basic Residues of the A Helix of Heparin Cofactor II to Heparin-or Dermatan Sulfate-Mediated Thrombin Inhibition FEBS Lett. 2002, 522, 147-150
30. Scott, J. E.; Heatley, F.; Wood, B. Comparison of Secondary Structures in Water of Chondroitin-4-Sulfate and Dermatan Sulfate: Implications in the Formation of Tertiary Structures Biochemistry 1995, 34, 15467-15474
31. Silipo, A.; Zhang, Z.; Cañada, F. J.; Molinaro, A.; Linhardt, R. J.; Jiménez-Barbero, J. Conformational Analysis of a Dermatan Sulfate-Derived Tetrasaccharide by NMR, Molecular Modeling, and Residual Dipolar Couplings ChemBioChem 2008, 9, 240-252
32. Verhamme, I. M.; Bock, P. E.; Jackson, C. M. The Preferred Pathway of Glycosaminoglycan-Accelerated Inactivation of Thrombin by Heparin Cofactor II J. Biol. Chem. 2004, 279, 9785-9795
33. Tollefsen, D. M. The Interaction of Glycosaminoglycans with Heparin Cofactor II: Structure and Activity of a High-Affinity Dermatan Sulfate Hexasaccharide Adv. Exp. Med. Biol. 1992, 313, 167-176